NCT03004404View on ClinicalTrials.gov

To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 12, 2017

Primary Completion Date

August 15, 2017

Study Completion Date

August 15, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Placebo

DRUG

BI 730357

powder for reconstitution of an oral solution (PfoS)

DRUG

BI 730357

BI 730357 film-coated tablet

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY